JPH07503240A - ３‐アリールインドールおよび１‐アリールインダゾール誘導体の精神病の治療のための使用 - Google Patents

３‐アリールインドールおよび１‐アリールインダゾール誘導体の精神病の治療のための使用

Info

Publication number
JPH07503240A
JPH07503240A JP5512865A JP51286593A JPH07503240A JP H07503240 A JPH07503240 A JP H07503240A JP 5512865 A JP5512865 A JP 5512865A JP 51286593 A JP51286593 A JP 51286593A JP H07503240 A JPH07503240 A JP H07503240A
Authority
JP
Japan
Prior art keywords
lower alkyl
hydrogen
treatment
cycloalkyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5512865A
Other languages
English (en)
Japanese (ja)
Inventor
アンデルセン・キム
スカルスフェルト・トールベン
Original Assignee
ハー・ルンドベック・アクティーゼルスカブ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ハー・ルンドベック・アクティーゼルスカブ filed Critical ハー・ルンドベック・アクティーゼルスカブ
Publication of JPH07503240A publication Critical patent/JPH07503240A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP5512865A 1992-01-23 1993-01-22 ３‐アリールインドールおよび１‐アリールインダゾール誘導体の精神病の治療のための使用 Pending JPH07503240A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK9284A DK8492D0 (da) 1992-01-23 1992-01-23 Behandling af psykoser
DK0084/92 1992-01-23
PCT/DK1993/000021 WO1993014758A1 (en) 1992-01-23 1993-01-22 Use of 3-arylindole and 3-arylindazole derivatives for the treatment of psychoses

Publications (1)

Publication Number Publication Date
JPH07503240A true JPH07503240A (ja) 1995-04-06

Family

ID=8089556

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5512865A Pending JPH07503240A (ja) 1992-01-23 1993-01-22 ３‐アリールインドールおよび１‐アリールインダゾール誘導体の精神病の治療のための使用

Country Status (11)

Country Link
EP (1) EP0621781A1 (da)
JP (1) JPH07503240A (da)
AU (1) AU670063B2 (da)
CA (1) CA2128699A1 (da)
CZ (1) CZ176494A3 (da)
DK (1) DK8492D0 (da)
NO (1) NO942686L (da)
RU (1) RU94035658A (da)
SK (1) SK86394A3 (da)
WO (1) WO1993014758A1 (da)
ZA (1) ZA93491B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054168A1 (en) * 1997-05-30 1998-12-03 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazole derivatives

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK206591D0 (da) * 1991-12-23 1991-12-23 Lundbeck & Co As H Behandling af psykoser
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8908085D0 (en) * 1989-04-11 1989-05-24 Lundbeck & Co As H New therapeutic use
DK181190D0 (da) * 1990-07-30 1990-07-30 Lundbeck & Co As H 3-aryl-indol- eller 3-aryl-indazolderivater

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998054168A1 (en) * 1997-05-30 1998-12-03 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazole derivatives
US6258825B1 (en) 1997-05-30 2001-07-10 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazole derivatives

Also Published As

Publication number Publication date
CA2128699A1 (en) 1993-08-05
ZA93491B (en) 1993-08-23
NO942686D0 (no) 1994-07-18
RU94035658A (ru) 1996-06-20
SK86394A3 (en) 1995-04-12
AU670063B2 (en) 1996-07-04
DK8492D0 (da) 1992-01-23
AU3449493A (en) 1993-09-01
CZ176494A3 (en) 1995-04-12
WO1993014758A1 (en) 1993-08-05
NO942686L (no) 1994-07-18
EP0621781A1 (en) 1994-11-02

Similar Documents

Publication Publication Date Title
CA2014208C (en) Selective blocking of spontaneously-active dopamine neurones in ventral tegmental area
US5238945A (en) Method of treating psychoses
TW520989B (en) Pharmaceutical composition for treating dementia, dementia of the Alzheimer's type, dyskinesias and behavioral manifestations of mental retardation, conduct disorder and autistic disorder
DE69706000T2 (de) Indolderivat als 5-HT1A Antagonist und als Inhibitor der Serotonin-Wiederaufnahme
WO2007093624A2 (en) Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
JPH064587B2 (ja) 新規なインドール誘導体およびその酸付加塩ならびにそれらを含有する精神病治療剤
US20220008414A1 (en) Pharmaceutical composition comprising histone deacetylase 6 inhibitors
CA2167004C (en) Agent for treating mental disorders associated with cerebrovascular disorders
EP2716302A1 (en) Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
CA2345406A1 (en) Analgesic
JPH08503449A (ja) 物質濫用疾患治療剤
JP2000198734A (ja) 胃運動性減弱および関連疾患の治療のための運動性増強薬
CN112204025B (zh) 用于治疗疼痛的化合物，包含其的组合物以及使用其的方法
JPH07503240A (ja) ３‐アリールインドールおよび１‐アリールインダゾール誘導体の精神病の治療のための使用
JP2002504134A (ja) 疼痛を治療するためのドラフラジン類似体の使用
JPH05255114A (ja) 非定型β−アドレナリン受容体作動薬の医学的用途
CN100354274C (zh) 神经变性疾病的预防和治疗药物
JP2002523363A (ja) 慢性疲労症候群および／または線維筋痛の処置のためのサブスタンスｐアンタゴニストの使用および慢性疲労症候群の処置のためのｎｋ−１レセプターアンタゴニストの使用
JPH05507933A (ja) Ｃｎｓおよび抗高血圧活性を有する置換１―（アルコキシフェニル）ピペラジン類
JPH07502517A (ja) 精神病の治療のためのアリールインドールの使用
GB2362826A (en) A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
JPH02180823A (ja) 医薬
KR20010099647A (ko) 신규 조성물
WO2003087091A1 (en) Novel crystal of quinoxalinedione derivative anhydride
TW200410691A (en) Use of 5-HT2 receptor antagonists